convEyXO

Laboratory Technician wanted 🔬   Nous sommes ravis de renouveler notre collaboration avec convEyXO, une biotech innovante et en pleine croissance, où règne un environnement dynamique, bienveillant et stimulant. Ils sont actuellement à la recherche d'un(e) 𝙇𝙖𝙗𝙤𝙧𝙖𝙩𝙤𝙧𝙮 𝙏𝙚𝙘𝙝𝙣𝙞𝙘𝙞𝙖𝙣 pour renforcer leur équipe !   Ce qu'on vous propose : 💡 Contribuer à un projet porteur de sens 🧬 Un environnement de travail moderne avec des technologies de pointe 🧪 Une mission variée où vos compétences feront la différence   Intéressé.e ? Envoyez-moi votre CV ou postulez directement. 📩 lena.rossignol@pahrtners.be 

Get to know the start-ups pitching at the HH Global Investor Forum & Innovation for Health on April 2-3, 2025, in Rotterdam, the Netherlands!   Frédéric Tonglet, CEO of convEyXO, will present his company at the Global Investor Forum on April 2, 2025.   Curious about ConvEyXO and its groundbreaking approach? Keep reading!   convEyXO is an advanced pre-clinical stage Belgian biotech company developing a therapeutic portfolio targeting anti-inflammatory and aging-related diseases. Built on their proprietary Technology Platform, they harness exosomes derived from immortalized cell lines and enhance their properties for specific indications by loading them with target-specific miRNAs.   As a #biotech company, ConvEyXO's exosomes possess inherent anti-inflammatory and regenerative properties, which we amplify by integrating miRNA to modulate key gene expression. As a #deeptech innovator, their Technology Platform addresses key challenges in the industrialization of loaded exosomes.   Learn more about Conveyxo and Frédéric Tonglet here: https://lnkd.in/ebw_ArBv   Are you ready to showcase your innovation for health? Don’t miss your chance to pitch! https://lnkd.in/eQ_A3AQu

🤩 Abstract submission and early registration for the #ISEV2025 Annual Meeting are now open! 🎼 Submit your abstracts before November 3rd: https://buff.ly/4e8W0Xu Eva Rohde, Eva-Maria Krämer-Albers, An Hendrix, Andreas Möller, Bo Li (李博), Edit Buzás, Johannes Grillari, Lucia Languino, Mario Gimona, Sun Young Lee, Wolfgang Holnthoner

Congratulations to convEyXO on being the latest addition to the "Global Database of Exosome Companies, 2024": https://lnkd.in/g8VVNaHr ConvEyXO, a Belgian biotech company, targets inflammatory and degenerative diseases with unmet medical needs by reducing inflammation and repairing tissue damages from cellular senescence with its Therapeutic Platform based on small Extracellular Vesicles (sEV or exosomes) secreted by Mesenchymal Stem Cells (MSCs), with their intrinsic immuno-modulatory and regenerative properties, amplified by loaded miRNA. ConvEyXO resolves sEV industrialization key challenges with a proprietary Technology Platform, making their therapies triple A with (1) homogenous industrial manufacturing from single cell line sourcing, with robust isolation, purification and characterization processes, (2) cost-efficient scalable production with patented process and proprietary 3D custom fixed-bed bioreactor and (3) Amplified sEV native properties by loading miRNA with a breakthrough microfluidic technology. #exosomes #extracellularvesicles #advancedtherapies Frédéric Tonglet

🚨 Job Alert!🚨 Join convEyXO as their new Senior Cell Culture #Technician! Come and join their Operations team and be part of something amazing 🚀 Apply now and help shape the future of life sciences! avec Frédéric Tonglet, Valérie Roels et Marie Coulon #Hiring #LifeSciences #cellculture #JobOpportunity #Biotech #CareerOpportunity